Search results for: 'a9aa 2020'

The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2019 that centered around the state of their laboratories in 2019 and their expectations for 2020. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-o...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire ...

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark in 2020. Healthcare will be among the top two priorities for voters in the 2020 presidential election in the US. In the European region, looming BREXIT indecision is likely to have a strong impact o...

20 Feb 2020  |  Europe  |  Market Outlook

EU Healthcare Predictions and Outlook, 2020

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

Infographics

×

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national health...

23 Aug 2019  |  Global  |  Market Outlook

Global Digital Health Outlook, 2020

Artificial Intelligence, Care Coordination, Cybersecurity, Data Analytics, Digital Therapeutics, and Telehealth Will Drive the Market

Infographics

×

This study predicts the ways that artificial intelligence, care coordination cybersecurity, data analytics, digital therapeutics, and telehealth will drive the digital health market in 2020. The report presents 9 predictions that are likely to prevail by 2020. Frost & Sullivan defines digital health as the application of data to the delivery of hea...

31 Aug 2016  |  North America  |  Market Research

Analysis of the US Digital and Computed Radiography Equipment Market

A Current Market Assessment and Outlook Through 2020

Infographics

×

As the oldest and most utilized medical imaging modality, diagnostic general X-ray imaging is a workhorse modality for any medical imaging provider and an anchor modality for any medical imaging equipment vendor. In the United States, the computed and digital radiography markets are on the brink of a new growth phase. New regulatory mandates, techn...

09 Jul 2020  |  North America  |  Market Research

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Infographics

×

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

29 Jan 2016  |  Africa  |  Market Research

Ethiopian Pharmaceutical Market, Forecast to 2020

Preference for Generic Prescription Drugs to Create New Market Dynamics, Demand for Anti-Infectives Rises

Infographics

×

This study offers an insight into the pharmaceutical industry of Ethiopia, where preference for generic, prescription drugs is growing. There is information on recent reforms introduced by the government (like tax benefits for in-country production, national strategy, and plan of action for pharmaceutical manufacturing development, growth and trans...